Ankylosis - 220 Studies Found

Completed : Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker
:
  • Arthritis, Rheumatoid
  • Spondylitis, Ankylosing

: 2010-02-18
: Drug: TNF blockers (infliximab, adalimumab, etanercept) Subjects enrolled, who were eligible to anti-TNF
Completed : T Cells and TNF: The Impact of TNF Blockade
:
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Psoriatic Arth
    : 2010-01-29
    : Drug: anti-TNF therapy (etanercept or adalimumab) Biological DMARD
Completed : Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment
:
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Ankylosing Spondy
    : 2009-05-13
Completed : Clinical Trial of Osteoporosis in Ankylosing Spondylitis
: Ankylosing Spondylitis
: 2009-03-09
Completed : An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
:
  • Spondylitis, Ankylosing
  • Arthritis, Rheumatoid
  • Psoriasis : 2008-09-24
    :
    • Drug: Infliximab; observational study

Completed : Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia
:
  • Ankylosing Spondylitis
  • Psoriatic Arthritis
  • Rheumatoid Arth
    : 2008-09-11
Completed : Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan
:
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Ankylosi
    : 2008-09-04
Completed : Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)
:
  • Arthritis, Rheumatoid
  • Spondylitis, Ankylosing
  • Arthritis, P
    : 2008-07-30
    : Biological: Infliximab Infliximab administered at a dose of 3-10 mg/kg at Week 0, Week 2, and Week 6, an
Completed : Post Marketing Surveillance of Remicade
:
  • Crohn's Disease
  • Ankylosing Spondylitis

: 2008-07-25
: Biological: Infliximab Infliximab 5 mg/kg IV given in a schedule according to the official label, based
Active, not recruiting : Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis
: Inflammatory Bowel Disease
: 2008-04-11
: Other: No intervention This is an observational study. Patients receiving infliximab or anti-TNF as per
<<< Previous | Next >>>